I35.0 I25.0 I50.0 I35.1 I34.0 I50.1 J84.1 J44.9
Conditions
Interventions
Group 1: Excess tissue and body fluids that remain after operations on the heart or lungs and would otherwise be disposed of (e.g. heart valves, blood vessels, heart and lung tissue, pericardial fluid
Sponsors
Universitätsklinikum Essen, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patient undergoing cardiac and/or lung surgery
Exclusion criteria
Exclusion criteria: Lack of consent Minority Psychiatric illnesses with resulting lack of legal capacity Chronic infectious diseases, especially HIV and hepatitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The functional analyses of the sample material planned as part of the project serve as the primary endpoint. These are molecular biological and biochemical methods such as PCR, Western blot, immunohistochemistry, FACS and histology. | — |
Secondary
| Measure | Time frame |
|---|---|
| Functional imaging using micro-CT/MRI of the samples serves as secondary endpoints. | — |
Countries
Germany
Contacts
Public ContactMoritz B. Immohr
Universitätsklinikum Essen, Klinik für Thorax- und Kardiovaskuläre Chirurgie
Outcome results
None listed